Key result
Transcatheter closure of a patent foramen ovale associated with a huge atrial septal aneurysm was successfully performed in a 48-year-old man with recurrent stroke, despite technical challenges.
Why the study?
Transcatheter treatment of atrial septal aneurysm associated with PFO is safe and effective for paradoxical embolism, but the procedure involves difficulties and complications.
Does transcatheter closure using an Amplatzer PFO occluder successfully treat a PFO with a huge ASA in a patient with recurrent stroke?
Case Report (n=1)
No
Does transcatheter closure using an Amplatzer PFO occluder successfully treat a PFO with a huge ASA in a patient with recurrent stroke?
Transcatheter closure of a PFO associated with a huge atrial septal aneurysm is technically challenging but feasible and safe.
Answers are grounded in this paper and cite their sources.
ASA with PFO may raise recurrent embolism risk; leaves open optimal management without higher-level evidence.
Patients with Atrial Septal Aneurysm (ASA) associated with Patent Foramen Oval (PFO) are at higher risk for recurrent paradoxical embolism compared to patients with PFO alone. The ASA may increase the PFO diameter due to the highly mobile atrial septal tissue, leading to a more frequent and wider opening of an otherwise small channel. Atrial septal aneurysm has been also considered a nidus for local thrombus formation with subsequent embolization. Transcatheter treatment of ASA associated with PFO is safe and effective in patients with paradoxical embolism. The procedure effectively abolishes right-to-left shunt and decreases atrial septal mobility. But, the procedure is not free of difficulties and complications. We report the case of a 48 years old man, with recurrent stroke, related to the presence of a PFO with a huge ASA, to show the difficulty of occlusion of this defect. The procedure was performed under general anesthesia to allow continuous multiplane transoesophageal imaging of the atrial septum and related structures. Stretched diameter of the PFO was determined by TOE measures. The availability of one type of occluder (Amplatzer PFO Occluder), the importance of the aneurysm, and the impact of the importance of aneurysm on the inconstant and variable size of the PFO may be causing difficulties during the procedure and turn the procedure to a challenge.
No takes yet. Share an insight, caveat, or question.
Afrikh et al. (2019) conducted a case report in Atrial Septal Aneurysm associated with Patent Foramen Ovale and recurrent stroke (n=1). Transcatheter closure (Amplatzer PFO occluder) was evaluated on Echocardiographic absence of residual shunt at discharge. Transcatheter closure of a patent foramen ovale associated with a huge atrial septal aneurysm was successfully performed in a 48-year-old man with recurrent stroke, despite technical challenges.
Synapse has enriched 10 related papers. Consider them for comparative context: